Back to catalogue
№ 079 41 filings · 2021-09-23 → 2026-08-17

BTG CONSULTING PLC

BTG
Financial Services Share price 109p Market cap £176m Overall fit 300 /1000

Fair to slightly cheap valuation with fortress balance sheet, but essentially no AI-receiver exposure and only modest operating leverage in a people-heavy professional services model — a solid stand-alone business but a weak fit for an AI-beneficiary, high-operating-leverage strategy.

Fair value range 115p–140p Mid case · £205m
Absolute upside +16.7% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • Clean, detailed segmental disclosure with published consensus ranges
  • 10+ year track record of consistent in-line-to-beat delivery
  • Two valuation methods converge on a similar range
Limits the call
  • Large statutory vs adjusted EPS gap creates multiple-choice ambiguity
  • Mixed business (restructuring / advisory / real estate) limits comparable precision
Methodology

Forward P/E on adjusted EPS, cross-checked with EV/EBITDA

In one line · bull case

A counter-cyclical, cash-generative UK advisory market leader with a fortress balance sheet and progressive dividend, available at ~10x forward earnings.

In one line · biggest risk

A stronger-than-expected transactional advisory recovery is required for the bull case; without it, incremental senior-hire investment continues to weigh on margins.

Drivers
AI beneficiary 20 /100
Spender on AI (Copilot rollout, Dynamics, AI for lead-gen) — no AI-driven revenue line; some sub-services face substitution risk.
Operating leverage 35 /100
People-heavy professional services with ~57% direct-cost ratio (mostly salaries); modest fixed-cost lever from senior hires' utilisation.
Earnings vs expectations 70 /100
Consistent modest beats or in-line delivery across the past 4 years; management guides conservatively.
Growth momentum 60 /100
10% revenue growth in FY26 (8% organic); FY27 guidance implies ~5-7% growth — stable mid-single-digit-plus.
Moat 45 /100
#1 in UK insolvency by volume gives real scale/reputation advantages, but the professional services market remains fragmented and competitive.
Earnings quality 55 /100
Cash conversion 83-90% is decent, but a large statutory vs adjusted gap from IFRS 3 deemed remuneration warrants some caution.
Management quality 65 /100
Long-tenured chairman; consistent execution over a decade; 9 years of dividend growth; sensibly-priced tuck-in M&A.
Cyclicality 35 /100
Restructuring is counter-cyclical, real estate valuations are defensive, transactional advisory is pro-cyclical — blended profile is quite resilient.
Leverage 15 /100
Net debt just £1.0m against £33.3m EBITDA; £25m RCF plus £10m accordion undrawn — fortress balance sheet.

BTG Consulting plc (BTG.L) — Research Note

Executive summary

BTG Consulting (rebranded from Begbies Traynor Group in September 2025) is a UK financial and real estate advisory firm operating in two divisions: restructuring/advisory (69% of revenue) and real estate (31%), where it ranks #1 nationally by volume of UK corporate insolvency appointments and is one of the largest commercial property agents in England. The group has delivered a decade-plus of profitable growth, with FY26 revenue up 10% to £168.5m and adjusted PBT up 6% to £25.0m, ahead of market expectations 2026-07 final results. The single most important valuation point today is that this is a well-run, counter-cyclical professional services business trading on ~10x forward earnings — attractive on its own terms, but with essentially no AI-receiver exposure and only modest operating leverage.

Fair value estimate

  • Methodology: Forward P/E multiple on adjusted EPS, cross-checked against EV/EBITDA.
  • Key assumptions: FY27 adjusted diluted EPS of ~11.7-12.0p (in line with guidance of adj PBT £26.0m-£26.9m at a 26% tax rate on ~167m diluted shares) 2026-07 final results. Apply 10-12x forward P/E, reflecting a UK small-cap professional services firm with consistent growth and a resilient business mix but limited operating leverage.
  • Fair value range: 115p – 140p per share = £185m – £226m market cap.
  • Cross-check: EV/EBITDA of ~5.3x currently vs. ~7-8x for peer FRP Advisory implies fair value closer to top of range.
  • Vs. current £175.7m market cap: +5% to +28% upside, midpoint ~+17%.

Note: Statutory EPS (5.1p) is materially below adjusted EPS (11.1p) because IFRS 3 "deemed remuneration" on acquisition earn-outs is expensed rather than capitalised. These are real cash costs but relate to acquisition consideration, so the adjusted measure is defensible as a proxy for underlying trading. A more conservative valuation using statutory EPS at 15-18x would give 77-92p — below current price.

Sector context

  • Sector: Financial Services (ICB) — professional services / advisory sub-sector.
  • Profile vs. peers: Quality is above peer average (10 consecutive years of growth, near net-cash balance sheet, 9 years of dividend growth); growth is broadly in line with peers; leverage is materially below peers.
  • Comparable listed peers: FRP Advisory Group (FRP.L) — most directly comparable UK-listed restructuring/advisory firm; K3 Capital Group (private since 2022); Savills (SVS.L) as a partial real-estate comp.

Investment thesis

  • Counter-cyclical earnings resilience with visible order book: Restructuring is 82% of the restructuring/advisory division with an order book of £88.2m (up from £78.6m), providing forward revenue visibility. Macroeconomic uncertainty drives demand — appointments include Sheffield Wednesday FC and 190+ appointments from the MFS insolvency 2026-07 final results.
  • Fortress balance sheet supports continued disciplined M&A: Net debt of just £1.0m against £33.3m adjusted EBITDA, £25m committed RCF plus £10m accordion undrawn, funding a track record of tuck-in acquisitions (Kirkby Diamond, Network Auctions, MVLOnline, Lameys) at sensible multiples 2026-07 final results, 2026-06 acquisition.
  • Progressive dividend and undemanding rating: 4.6p dividend (9 consecutive years of growth), 4.2% yield at current price, on ~10x forward earnings with mid-single-digit organic growth 2026-07 final results.

Key risks

  • Transactional/advisory softness: Deal advisory margins fell to 25.4% (from 26.5%) as M&A activity remained subdued; a prolonged transactional freeze would keep this segment underperforming 2026-07 final results.
  • Acquisition consideration overhang and margin dilution: £10.0m of deemed remuneration still to be charged post-2026, of which £5.5m hits FY27 P&L; recent senior hires have compressed margins (adjusted EBITDA margin dropped to 19.8% from 20.6%) 2026-07 final results.
  • Structural AI substitution risk in advisory work (not disclosed but inferred): Some sub-segments (forensic accounting, routine due diligence, standardised valuations) are exposed to productivity gains from AI tools that could compress fees over time; the group is investing in Copilot and Dynamics but is a spender on AI, not a beneficiary.

Operating leverage

BTG is a people-heavy professional services business — direct costs (largely salaries) were £95.7m against revenue of £168.5m, giving a gross margin of ~43% 2026-07 final results. Fixed central costs are only £11.2m (6.6% of revenue), and depreciation is £5m — so most operating costs scale with revenue and headcount. Management explicitly cites operating leverage in commentary ("as recent investment in senior capability is increasingly utilised, we expect to see a corresponding improvement in margins") but the magnitude is modest: a 10-20% revenue beat on the current £168m base would likely add roughly £5-7m of incremental profit at ~50% incremental margin (professional services on already-hired capacity), i.e. ~25-30% uplift to operating profit — well short of the "multiples of profit" characteristic of true operating-leverage plays. The business does have an interesting fixed-cost lever in its recent senior hires (partner-level fee earners with high billable ceilings) — if utilisation rises, drop-through improves — but this is a step-change dynamic, not a genuine platform effect.

Value-trap signals

None identified. Revenue growing, dividend growing 9 years running, near net-cash, no going-concern issues, unqualified audit report, no visible related-party or governance concerns.

Earnings vs. expectations

  • FY26 (July 2026): Adj PBT £25.0m vs. guidance £24.1m consensus / range £23.7-£24.4m — beat (upgraded in May 2026 trading update).
  • FY25 (July 2025): Adj PBT £23.5m vs. £23.0-£24.3m range — beat (top of range).
  • H1 FY26 (Dec 2025): Adj PBT £12.1m — in line; full-year guidance maintained.
  • FY24 (July 2024): Adj PBT £22.0m vs. £21.9-£22.5m — in line/slight beat.
  • FY23 (July 2023): Adj PBT £20.7m — beat original expectations.

Pattern: Consistent modest beats or in-line delivery over the past 4 years; management guides conservatively and has established credibility.

Conviction

Conviction: 4 (high).

  • Anchors: (1) Very clean disclosure with detailed segmental data, cash conversion metrics and forward market-consensus figures explicitly published by the company; (2) 10+ year track record of consistent execution provides high confidence in earnings quality of the underlying business; (3) two valuation methodologies (P/E and EV/EBITDA) both point to a similar fair value zone.
  • Caveats: (1) Large gap between statutory (£14.1m PBT) and adjusted (£25.0m PBT) earnings due to IFRS 3 deemed remuneration — the "right" multiple to apply is debatable; (2) mix of divisions (restructuring vs. real estate vs. transactional advisory) makes the appropriate comparable set imperfect.

Filings consulted · 48

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-17Notice OF Agm2026-08-17_9726077_notice-of-agm.md0.30
  2. 2026-07-06Final Results2026-07-06_9652936_final-results.md1.00
  3. 2026-06-05Acquisition2026-06-05_9603102_acquisition.md0.75
  4. 2026-05-21Year End Trading Update2026-05-21_9578735_year-end-trading-update.md0.85
  5. 2026-02-24Third Quarter Trading Update2026-02-24_9443321_third-quarter-trading-update.md0.85
  6. 2025-12-09Half Year Results2025-12-09_9283677_half-year-results.md0.77
  7. 2025-11-26Acquisition2025-11-26_9257233_acquisition.md0.64
  8. 2025-11-25Acquisition2025-11-25_9254669_acquisition.md0.64
  9. 2025-11-20Half Year Trading Update2025-11-20_9245436_half-year-trading-update.md0.77
  10. 2025-09-18Result OF Agm2025-09-18_9116943_result-of-agm.md0.26
  11. 2025-09-18Agm Statement2025-09-18_9115184_agm-statement.md0.34
  12. 2025-08-18Notice OF Agm2025-08-18_9062072_notice-of-agm.md0.20
  13. 2025-07-08Final Results2025-07-08_8967632_final-results.md0.65
  14. 2025-05-23Year End Trading Update2025-05-23_8893635_year-end-trading-update.md0.55
  15. 2025-02-20Third Quarter Trading Update2025-02-20_8744377_third-quarter-trading-update.md0.55
  16. 2024-12-10Half Year Results2024-12-10_8600397_half-year-results.md0.58
  17. 2024-12-02Acquisition2024-12-02_8583087_acquisition.md0.49
  18. 2024-11-18Half Year Trading Update2024-11-18_8555088_half-year-trading-update.md0.58
  19. 2024-09-17Result OF Agm2024-09-17_8421209_result-of-agm.md0.20
  20. 2024-09-17Agm Statement2024-09-17_8419675_agm-statement.md0.26
  21. 2024-07-09Final Results2024-07-09_8300291_final-results.md0.45
  22. 2024-05-21Year End Trading Update2024-05-21_8209799_year-end-trading-update.md0.38
  23. 2024-02-263rd Quarter Trading Update And New Debt Facility2024-02-26_8054750_3rd-quarter-trading-update-and-new-debt-facility.md0.38
  24. 2023-12-12Investor Presentation Via Investor Meet Company2023-12-12_7937834_investor-presentation-via-investor-meet-company.md0.32
  25. 2023-12-12Acquisition2023-12-12_7935761_acquisition.md0.34
  26. 2023-12-11Half Year Results2023-12-11_7933209_half-year-results.md0.41
  27. 2023-11-20Half Year Trading Update2023-11-20_7890415_half-year-trading-update.md0.41
  28. 2023-11-08Acquisition2023-11-08_7866830_acquisition.md0.34
  29. 2023-09-19Result OF Agm2023-09-19_7764489_result-of-agm.md0.14
  30. 2023-09-19Agm Statement2023-09-19_7763205_agm-statement.md0.18
  31. 2023-07-11Final Results2023-07-11_7624318_final-results.md0.25
  32. 2023-05-22Year End Trading Update2023-05-22_7535360_year-end-trading-update.md0.21
  33. 2023-05-04Acquisition2023-05-04_7511916_acquisition.md0.19
  34. 2023-03-02Acquisition2023-03-02_7283899_acquisition.md0.19
  35. 2023-02-27Third Quarter Trading Update2023-02-27_7235702_third-quarter-trading-update.md0.21
  36. 2022-12-13Half Year Results2022-12-13_7406992_half-year-results.md0.23
  37. 2022-11-17Trading Update2022-11-17_7411986_trading-update.md0.21
  38. 2022-09-22Agm Statement2022-09-22_7419199_agm-statement.md0.10
  39. 2022-07-25Acquisition2022-07-25_7134035_acquisition.md0.19
  40. 2022-07-19Final Results For The Year Ended 30 April 20222022-07-19_7036783_final-results-for-the-year-ended-30-april-2022.md0.25
  41. 2022-07-08Investor Presentation BY Webinar2022-07-08_6921250_investor-presentation-by-webinar.md0.17
  42. 2022-06-27Acquisition2022-06-27_7071463_acquisition.md0.19
  43. 2022-05-19Year End Trading Update And Notice OF Results2022-05-19_6933014_year-end-trading-update-and-notice-of-results.md0.21
  44. 2022-02-23Third Quarter Trading Update2022-02-23_6924202_third-quarter-trading-update.md0.21
  45. 2022-01-10Acquisition2022-01-10_6805711_acquisition.md0.19
  46. 2021-12-14Half Year Results2021-12-14_6829777_half-year-results.md0.23
  47. 2021-11-18Trading Update And Notice OF Half Year Results2021-11-18_6790565_trading-update-and-notice-of-half-year-results.md0.23
  48. 2021-09-23Agm Statement2021-09-23_6557458_agm-statement.md0.10

This research note was authored by a large language model after reading 41 regulatory filings published between 2021-09-23 and 2026-08-17. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.